Feb 19, 2021 (SUPER MARKET RESEARCH via COMTEX) -- According to a new report by Expert Market Research titled, 'Global Regenerative Medicine Market Report and Forecast 2020-2025', the global regenerative medicine market size was around USD 2.80 million in 2019. The industry is further expected to grow at a CAGR of 11.7% between 2020 and 2025.
Note 1: For a snapshot of the primary and secondary data of the market (2015-2025), along with business strategies and detailed market segmentation, please click on request sample report. The sample report shall be delivered to you within 24 hours.
Request a free sample copy in PDF or view the report summary@ https://www.expertmarketresearch.com/reports/regenerative-medicine-market/requestsample
North America dominates the industry, accounting for a significant share in the global regenerative medicine market. The industry growth in the region can be attributed to the increased penetration of the key players, and the availability of advanced research institutes and technologies. Researchers supported by the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services, developed a clinical-grade stem cell line in 2016, having the ability to boost the advance of new medical applications and cell-based therapies for diseases like Alzheimer's disease, Parkinson's disease, spinal cord injury, diabetes, and muscular dystrophy. The Asia Pacific is expected to be one of the major emerging markets for regenerative medicines over the forecast period owing to the rising population and increased government expenditure in the research sector.
Read full report summary with Table of Contents- https://www.expertmarketresearch.com/reports/regenerative-medicine-market
Market Breakup by Technology:
Stem Cell Therapy
Market Breakup by Application:
Bone Graft Substitutes
Central Nervous System
Market Breakup by Region:
1 North America
1.1 United States of America
2.2 United Kingdom
3 Asia Pacific
4 Latin America
5 Middle East & Africa
5.1 Saudi Arabia
5.2 United Arab Emirates
5.4 South Africa
Competitive Landscape & Supplier Analysis:
Novartis AG /zigman2/quotes/203243705/composite NVS -0.76%
Vericel /zigman2/quotes/200874113/composite VCEL +0.12%